 CRANBURY, N.J., Nov. 22, 2021 GLOBE NEWSWIRE -- PMV Pharmaceuticals, Inc. Nasdaq: PMVP, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President Chief Executive Officer, will represent PMV Pharma in a Fireside Chat at the Evercore ISI 4th Annual HealthCONx Conference taking place November 30 December 2, 2021. The company will also participate in one-on-one investor meetings at the conference. 